Fortress Biotech, Inc.
FBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $100,805 | $49,996 | $41,262 | $41,089 |
| - Cash | $86,218 | $74,386 | $91,339 | $57,263 |
| + Debt | $68,293 | $69,219 | $74,236 | $75,960 |
| Enterprise Value | $82,880 | $44,829 | $24,159 | $59,786 |
| Revenue | $17,631 | $16,413 | $13,139 | $15,120 |
| % Growth | 7.4% | 24.9% | -13.1% | – |
| Gross Profit | $11,876 | $11,474 | $8,349 | $9,315 |
| % Margin | 67.4% | 69.9% | 63.5% | 61.6% |
| EBITDA | $12,425 | -$8,424 | -$20,990 | -$21,780 |
| % Margin | 70.5% | -51.3% | -159.8% | -144% |
| Net Income | $5,850 | $15,486 | -$10,584 | -$6,765 |
| % Margin | 33.2% | 94.4% | -80.6% | -44.7% |
| EPS Diluted | 0.11 | 0.45 | -0.48 | -0.37 |
| % Growth | -75.6% | 193.8% | -29.7% | – |
| Operating Cash Flow | -$6,110 | -$27,560 | -$19,563 | -$12,907 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6,110 | -$27,560 | -$19,563 | -$12,907 |